Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drugs causing dyslipoproteinemia

W T Donahoo1, L A Kosmiski, R H Eckel

  • 1Department of Medicine, University of Colorado Health Sciences Center, Denver, USA.

Endocrinology and Metabolism Clinics of North America
|October 24, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response by Ward et al to Letter Regarding Article, "Statin Toxicity: Mechanistic Insights and Clinical Implications".

Circulation research·2019
Same author

Evidence of a gap in understanding obesity among physicians.

Obesity science & practice·2018
Same author

Effect of ranolazine on glycaemic control in patients with type 2 diabetes treated with either glimepiride or metformin.

Diabetes, obesity & metabolism·2016
Same author

Dietary triglycerides act on mesolimbic structures to regulate the rewarding and motivational aspects of feeding.

Molecular psychiatry·2014
Same author

Obesity development in caspase-1-deficient mice.

International journal of obesity (2005)·2013
Same author

Adults with type 1 diabetes eat a high-fat atherogenic diet that is associated with coronary artery calcium.

Diabetologia·2009

Certain blood pressure medications, like diuretics and beta-blockers, negatively impact serum lipids. Conversely, alpha-blockers improve lipid profiles, while others are neutral. Hormone therapies show varied lipid effects.

Area of Science:

  • Pharmacology
  • Endocrinology
  • Cardiovascular Medicine

Background:

  • Antihypertensive medications and hormone therapies can significantly alter serum lipid profiles.
  • Understanding these effects is crucial for managing cardiovascular risk, especially in patients with dyslipidemia.

Purpose of the Study:

  • To review the impact of various antihypertensive agents and hormone therapies on serum lipid levels.
  • To highlight the differential effects of these drugs on lipid parameters like HDL-C, LDL-C, and triglycerides.

Main Methods:

  • Literature review and analysis of existing studies on drug effects on serum lipids.
  • Categorization of antihypertensive drugs (diuretics, beta-blockers, alpha-blockers, calcium channel blockers, ACE inhibitors, ARAs) and hormone therapies (steroids, retinoids, interferons) based on their lipid profiles.

Related Experiment Videos

Main Results:

  • Diuretics and beta-blockers adversely affect lipids; alpha-blockers show beneficial effects.
  • Most other antihypertensives are lipid-neutral. Steroid hormones, retinoids, and interferons exhibit variable and often detrimental effects on lipids.
  • Post-transplant dyslipidemia is often linked to immunosuppressants like glucocorticoids, cyclosporine, and FK-506.

Conclusions:

  • Drug-induced dyslipidemia is a significant concern, particularly with certain antihypertensives and hormone therapies.
  • Careful patient monitoring and therapeutic adjustments are necessary to mitigate cardiovascular risks associated with these medications.